November 2023 – Adnexus

BRIDGING BIOLOGY AND TECHNOLOGY: PIONEERING TOMORROW’S HEALTHCARE SOLUTIONS

Home
Company

About Adnexus

Management

Adnexus One Health

Therapeutic Pipelines

Market Projections & Pipeline

Intellectual Property
Research & Development
Artificial Intelligence Platform

BioNexus A.I. Platform

About BioNexus AI

Alzheimer’s Disease

BioNexus Human Microbiome Consortium

Longevity and Aging

Parkinson’s Disease

Sepsis
Partners
Contact Us

Follow us on

Home
Company

About Adnexus

Management

Adnexus One Health

Therapeutic Pipelines

Market Projections & Pipeline

Intellectual Property
Research & Development
Artificial Intelligence Platform

BioNexus A.I. Platform

About BioNexus AI

Alzheimer’s Disease

BioNexus Human Microbiome Consortium

Longevity and Aging

Parkinson’s Disease

Sepsis
Partners
Contact Us

Month: November 2023

Go with your gut

Go with your gut

November 10, 2023

Search

Recent Posts

Go with your gut
Drugs and Droids-Harnessing the Potential of AI in Drug Discovery
Enzolytics, Inc. announces the execution of the binding business combination agreement for the sale of Biogenysis, Inc. (“BGEN”) and Virogentics Inc. (“VIRO”), the operating subsidiaries of Enzolytics Inc.
Biogenysis Inc. Announces a Collaboration with Khalpey AI Lab in using Artificial Intelligence (AI) for Unveiling Potential Biomarkers and Predicting the Onset or Prevention of Alzheimer’s Disease
Enzolytics Inc. Continues Progress with Business Combination; Biogenysis Announces Team and Plans for Success

Archives

November 2023
September 2023
June 2023
April 2023

Categories

KEEP IN TOUCH

inquiries@adnexus.com

Navigate

Research & Development

BioNexus Artificial Intelligence Platform

©2024 Adnexus | All rights reserved

Website developed by Plastic Duck Armada (Pty) Ltd

Close

Search

Hit enter to search or ESC to close

Search for:

By using this website, you agree to our cookie policy. Close